🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Carisma Therapeutics, Inc.
Market Cap: Lowest
Employees: Low
chimeric antigen receptors (CAR) macrophages
Carisma Therapeutics, Inc. is a biopharmaceutical company that develops chimeric antigen receptors (CAR) macrophages for the treatment of solid tumors, leveraging advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cellular therapy.
Symbol: CARM
Recent Price: $0.44
Industry: Biotechnology
CEO: Mr. Steven Kelly
Sector: Healthcare
Employees: 107
Address: 3675 Market St., Philadelphia, PA 19104
Phone: 484 899 0326
Leadership
- Steven Kelly, President & CEO
- Michael Klichinsky, PharmD, PhD, Co-Founder and Chief Scientific Officer
- Eugene Kennedy, MD, Chief Medical Officer
- Kenneth Locke, Senior Vice President, Technical Operations
- Richard Morris, Chief Financial Officer
- Terry Shields, Senior Vice President, Human Resources
- Eric Siegel, General Counsel and Corporate Secretary
- Tom Wilton, Chief Business Officer
- Sascha Abramson, PhD, Vice President, Scientific Operations
- Heather Ansorge, PhD, VP, Program and Portfolio Management
- Thomas Condamine, PhD, Vice President, Discovery and Translational Sciences
Last updated: 2024-12-31